The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients

References

• Mosharafa AA , Torky MH , El Said WM , Meshref A . Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology. 2011;78 (3):511–5.
   PubMed Web of Science ®Google Scholar
• Feliciano J , Teper E , Ferrandino M , Macchia J , Blank W , Grunberger I et al . The incidence of fluoroquinolone resistant infections after prostate biopsy — are fluoroquinolones still effective prophylaxis? J Urol. 2008;179 (4):952–5.
   PubMedGoogle Scholar
• Crawford ED , Haynes AL Jr , Story MW , Borden TA . Prevention of urinary tract infection and sepsis following transrecal prostate biopsy. J Urol. 1982;127 (3):449–51.
   PubMed Web of Science ®Google Scholar
• Shigehara K , Miyagi T , Nakashima T , Shimamura M . Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother. 2008;14:40–3.
   PubMedGoogle Scholar
• Aron M , Rajeev TP , Gupta NP . Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000;85 (6):682–5.
   PubMed Web of Science ®Google Scholar
• Davis M , Sofer M , Kim SS , Soloway MS . The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol. 2002;167 (2):566–70.
   PubMed Web of Science ®Google Scholar
• Gundogdu A , Long YB , Katouli M . Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients. Eur J Clin Microbiol Infect Dis. 2012;31 (11):3107–16.
   PubMed Web of Science ®Google Scholar
• Cannon GM Jr , Smaldone MC , Paterson DL . Extended spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. Can J Urol. 2007;14 (4):3653–5.
   PubMedGoogle Scholar
• Drieux L , Brossier F , Sougakoff W , Jarlier V . Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2012;14 (Suppl 1):90–103.
   Google Scholar
• Kapoor DA , Klimberg IW , Malek GH , Wegenke JD , Cox CE , Patterson AL , et al . Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998;52 (4):552–8.
   PubMed Web of Science ®Google Scholar
• Sabbagh R , McCormack M , Peloquin F , Faucher R , Perreault JP , Perrotte P , et al . A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol. 2004;11 (2):2216–9.
   PubMedGoogle Scholar
• Chen YH , Ko WC , Hsueh PR . The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens. Eur J Clin Microbiol Infect Dis. 2012;31 (8):1699–704.
   PubMed Web of Science ®Google Scholar
• Djavan B , Waldert M , Zlotta A , Dobronski P , Seitz C , Remzi M , et al . Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001;166 (3):856–60.
   PubMed Web of Science ®Google Scholar
• Rodríguez LV , Terris MK . Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol. 1998;160 (6):2115–20.
   PubMed Web of Science ®Google Scholar
• Lindert KA , Kabalin JN , Terris MK . Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164 (1):76–80.
   PubMed Web of Science ®Google Scholar
• Nam RK , Saskin R , Lee Y , Liu Y , Law C , Klotz LH , et al . Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2010;183 (5):963–9.
   PubMedGoogle Scholar
• Otrock ZK , Oghlakian GO , Salamoun MM , Haddad M , Bizri AR . Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol. 2004;25 (10):873–7.
   PubMed Web of Science ®Google Scholar
• Ozden E , Bostancı Y , Yakupoglu KY , Akdeniz F , Yılmaz AF , Tulek N , et al . Incidence of acute prostatitis caused by extended-spectrum β-lactamase producing E coli after transrectal prostate biopsy. Urology. 2009;74 (1):119–22.
   PubMed Web of Science ®Google Scholar
• Kanafani Z , Mehio-Sibai A , Araj GF , Kanaan M , Kanj SS . Epidemiology and risk factors for extended spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control. 2005;33 (6):326–32.
   PubMed Web of Science ®Google Scholar
• Yagci D , Yoruk F , Azap A , Memikooglu O . Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy. Antimicrob Agents Chemother. 2009;53 (3):1287–9.
   PubMed Web of Science ®Google Scholar
• Lautenbach E , Patel J , Bilker W , Edelstein PH , Fishman NO . Extended spectrum-lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32 (8):1162–71.
   PubMed Web of Science ®Google Scholar
• Kim SJ , Kim SI , Ahn HS , Choi JB , Kim YS , Kim SJ . Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean J Urol. 2010;51 (6):426–30.
   PubMedGoogle Scholar